Aduhelm

Nursing home visitors in Rhode Island must now be fully vaccinated or test negative for COVID … Frist named CEO at naviHealth … Medicare proposes controversial Alzheimer’s drug coverage only for...

With the 50% price drop of Aduhelm on January 1, there is good reason for CMS to reassess a hefty proposed premium hike for 2022, the U.S. health secretary said. On Wednesday, CMS is expected to announce...

U.S. Secretary of Health and Human Services Xavier Becerra on Monday ordered Medicare to reassess a big premium increase facing millions of seniors this year, after an expensive new Alzheimer’s drug...

Amyloid-related imaging abnormalities-edema seen on brain MRI most common adverse event in participants receiving high-dose aducanumab

Aduhelm tied to brain swelling in nearly 40% of patients, but few have symptoms, drugmaker says … Operators push back as nursing homes fined nearly $1 million over state vaccination rules … BP drug...

New COVID infections drop by 53% when people wear masks: large study finds … FDA investigating death of patient taking new Alzheimer’s drug Aduhelm … CDC probes massive college influenza outbreak...

OSHA suspends implementation of COVID-19 vaccine mandate for businesses … Feds expected to OK Pfizer’s COVID vaccine boosters for all adults; Moderna requests the same for its shot … 12 more...

The next hospital crisis may be dementia behavioral emergencies, psychiatrist says … Neurologists prescribing Alzheimer’s drug Aduhelm talk about practices and payments … Patients with diabetes may...

Drugmakers Eisai and Biogen are putting the Food and Drug Administration to the test with a request to approve a second Alzheimer’s drug that works like aducanumab (Aduhelm), the new, yet controversial,...

The outlook for the Alzheimer’s drug aducanumab (Aduhelm) is looking up, investigators say. There are small increases in the number of Aduhelm prescribers, and an uptick in patients for whom the...